These 4 Measures Indicate That Koninklijke Philips (AMS:PHIA) Is Using Debt Extensively
Jan 06
Have your own idea? Try our Stock Screener
Dutch (AEX) Healthcare Sector Analysis
UpdatedJan 12, 2026
DataAggregated Company Financials
Companies4
- 7D9.3%
- 3M6.6%
- 1Y3.0%
- YTD9.3%
In the last week, the Healthcare industry is up 9.3%, with all of the companies up. In the last 12 months, the industry was up 3.0%. Earnings are forecast to grow by 30% annually.
Sector Valuation and Performance
Has the Dutch Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 12 Jan 2026 | €27.2b | €18.4b | -€283,026,709.20 | 1752x | -96.1x | 1.5x |
| Wed, 10 Dec 2025 | €24.9b | €18.4b | -€283,026,785.60 | 1586.7x | -88.1x | 1.4x |
| Fri, 07 Nov 2025 | €26.0b | €18.4b | -€135,037,940.00 | 134.3x | -192.5x | 1.4x |
| Sun, 05 Oct 2025 | €25.8b | €18.4b | -€137,915,760.00 | 133.5x | -186.9x | 1.4x |
| Tue, 02 Sep 2025 | €25.1b | €18.4b | -€146,017,340.00 | 132.1x | -172.1x | 1.4x |
| Thu, 31 Jul 2025 | €24.9b | €18.4b | -€151,369,233.60 | 131.6x | -164.4x | 1.4x |
| Sat, 28 Jun 2025 | €21.8b | €18.5b | €26.0m | 82.2x | 837.9x | 1.2x |
| Mon, 26 May 2025 | €20.9b | €18.6b | €25.7m | 78x | 815.2x | 1.1x |
| Wed, 23 Apr 2025 | €21.5b | €18.6b | -€855,646,427.30 | n/a | -25.1x | 1.2x |
| Fri, 21 Mar 2025 | €24.3b | €18.6b | -€855,443,380.50 | n/a | -28.4x | 1.3x |
| Sun, 16 Feb 2025 | €27.4b | €18.6b | -€548,929,061.46 | n/a | -50x | 1.5x |
| Tue, 14 Jan 2025 | €25.6b | €18.6b | -€608,235,465.48 | n/a | -42.1x | 1.4x |
| Thu, 12 Dec 2024 | €25.5b | €18.6b | -€608,975,544.14 | n/a | -41.8x | 1.4x |
| Sat, 09 Nov 2024 | €25.5b | €18.6b | -€608,211,215.03 | n/a | -41.9x | 1.4x |
| Mon, 07 Oct 2024 | €29.7b | €18.7b | -€597,121,508.69 | 54.4x | -49.8x | 1.6x |
| Wed, 04 Sep 2024 | €27.6b | €18.7b | -€610,741,101.35 | 55x | -45.1x | 1.5x |
| Fri, 02 Aug 2024 | €26.4b | €18.6b | -€609,054,516.93 | 53.6x | -43.4x | 1.4x |
| Sun, 30 Jun 2024 | €24.1b | €18.6b | -€848,077,651.48 | 50.1x | -28.4x | 1.3x |
| Tue, 28 May 2024 | €25.7b | €18.6b | -€847,692,900.75 | 54.2x | -30.3x | 1.4x |
| Thu, 25 Apr 2024 | €20.3b | €18.6b | -€543,586,298.24 | n/a | -37.3x | 1.1x |
| Sat, 23 Mar 2024 | €19.7b | €18.6b | -€569,437,457.31 | n/a | -34.5x | 1.1x |
| Mon, 19 Feb 2024 | €20.6b | €18.9b | -€725,274,821.01 | n/a | -28.4x | 1.1x |
| Wed, 17 Jan 2024 | €23.1b | €19.3b | -€877,643,833.00 | n/a | -26.3x | 1.2x |
| Fri, 15 Dec 2023 | €22.0b | €19.3b | -€877,337,451.00 | n/a | -25.1x | 1.1x |
| Sun, 12 Nov 2023 | €20.1b | €19.3b | -€876,951,549.00 | n/a | -22.9x | 1x |
| Tue, 10 Oct 2023 | €19.5b | €19.1b | -€2,302,957,984.00 | n/a | -8.5x | 1x |
| Thu, 07 Sep 2023 | €21.9b | €19.1b | -€2,427,013,221.00 | n/a | -9x | 1.1x |
| Sat, 05 Aug 2023 | €21.2b | €19.1b | -€2,425,177,510.00 | n/a | -8.7x | 1.1x |
| Mon, 03 Jul 2023 | €21.9b | €18.8b | -€2,534,235,327.00 | n/a | -8.6x | 1.2x |
| Wed, 31 May 2023 | €20.8b | €18.8b | -€2,533,096,318.00 | n/a | -8.2x | 1.1x |
| Fri, 28 Apr 2023 | €20.4b | €18.8b | -€2,551,232,253.00 | 53.3x | -8x | 1.1x |
| Sun, 26 Mar 2023 | €16.6b | €18.5b | -€2,026,120,270.00 | 51.1x | -8.2x | 0.9x |
| Tue, 21 Feb 2023 | €18.1b | €18.6b | -€1,792,028,603.00 | 228.8x | -10.1x | 1x |
| Thu, 19 Jan 2023 | €18.0b | €18.1b | -€1,537,216,320.00 | 275.4x | -11.7x | 1x |
Price to Earnings Ratio
-11.7x
Current Industry PE
- Investors are optimistic on the Dutch Healthcare industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 1.2x is lower than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Trends
Which industries have driven the changes within the Dutch Healthcare sector?
| NL Market | 1.43% | |
| Healthcare | 9.30% | |
| Medical Equipment | 9.99% | |
| Biotech | 4.05% | |
| Pharma | 0% | 0 |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 4.8x.
- Analysts are expecting annual earnings growth of 26.7% and investors are willing to pay a premium for that growth.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 54% over the next 5 years.
- In contrast, the Medical Equipment industry is expected to see its earnings grow by 27% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHIA Koninklijke Philips | €25.43 | 10.0% +€2.2b | 0.5% | PE139.8x | |
| PHARM Pharming Group | €1.61 | 10.2% +€102.1m | 77.0% | PE3364.3x | |
| GLPG Galapagos | €28.36 | 0.7% +€13.2m | 13.2% | PS6.5x | |
| VVY Vivoryon Therapeutics | €1.56 | 5.3% +€2.3m | -22.0% | PB14.5x |